Albanell Mestres, J., Pérez García, J. M., Gil Gil, M., Curigliano, G., Ruíz Borrego, M., Comerma, L., . . . Llombart Cussac, A. (2022). Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.
Citación estilo ChicagoAlbanell Mestres, Joan, et al. Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings From the Phase II BioPER Trial. 2022.
Cita MLAAlbanell Mestres, Joan, et al. Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings From the Phase II BioPER Trial. 2022.
Precaución: Estas citas no son 100% exactas.